JPWO2020146902A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020146902A5 JPWO2020146902A5 JP2021540477A JP2021540477A JPWO2020146902A5 JP WO2020146902 A5 JPWO2020146902 A5 JP WO2020146902A5 JP 2021540477 A JP2021540477 A JP 2021540477A JP 2021540477 A JP2021540477 A JP 2021540477A JP WO2020146902 A5 JPWO2020146902 A5 JP WO2020146902A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- car
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025126649A JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変ｍｕｃ１＊抗体およびその使用 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962791661P | 2019-01-11 | 2019-01-11 | |
| US62/791,661 | 2019-01-11 | ||
| USPCT/US2019/019566 | 2019-02-26 | ||
| PCT/US2019/019566 WO2019165421A1 (en) | 2018-02-26 | 2019-02-26 | Diagnostic methods using anti-muc1* antibodies |
| USPCT/US2019/021556 | 2019-03-11 | ||
| PCT/US2019/021556 WO2019173815A2 (en) | 2018-03-09 | 2019-03-11 | Method for anti-muc1* car t cell stimulation |
| PCT/US2020/013410 WO2020146902A2 (en) | 2019-01-11 | 2020-01-13 | Anti-variable muc1* antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126649A Division JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変ｍｕｃ１＊抗体およびその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022527144A JP2022527144A (ja) | 2022-05-31 |
| JPWO2020146902A5 true JPWO2020146902A5 (enExample) | 2023-04-18 |
Family
ID=71521210
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540477A Pending JP2022527144A (ja) | 2019-01-11 | 2020-01-13 | 抗可変ｍｕｃ１＊抗体およびその使用 |
| JP2025126649A Pending JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変ｍｕｃ１＊抗体およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025126649A Pending JP2025172739A (ja) | 2019-01-11 | 2025-07-29 | 抗可変ｍｕｃ１＊抗体およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220184120A1 (enExample) |
| EP (1) | EP3908603A4 (enExample) |
| JP (2) | JP2022527144A (enExample) |
| CN (2) | CN113853386A (enExample) |
| AU (1) | AU2020205735A1 (enExample) |
| CA (1) | CA3126391A1 (enExample) |
| IL (1) | IL284772A (enExample) |
| WO (1) | WO2020146902A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2022027039A1 (en) * | 2020-07-29 | 2022-02-03 | Minerva Biotechnologies Corporation | Anti-variable muc1* antibodies and uses thereof |
| US11746159B2 (en) | 2015-02-10 | 2023-09-05 | Minerva Biotechnologies Corporation | Humanized anti-MUC1* antibodies |
| JP7411559B2 (ja) * | 2018-02-26 | 2024-01-11 | ミネルバ バイオテクノロジーズ コーポレーション | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
| US20230242678A1 (en) | 2020-06-26 | 2023-08-03 | Minerva Biotechnologies Corporation | Anti-nme antibody and method of treating cancer or cancer metastasis |
| KR20230061486A (ko) * | 2020-09-04 | 2023-05-08 | 밀테니 비오텍 비.브이. & 씨오. 케이지 | 면역 세포 내 어댑터의 유도성 발현을 위한 시스템 |
| US20250154494A1 (en) * | 2021-11-09 | 2025-05-15 | Janssen Biotech, Inc. | Microfluidic Co-Encapsulation Device and System and Methods for Identifying T-Cell Receptor Ligands |
| WO2023123195A1 (zh) * | 2021-12-30 | 2023-07-06 | 深圳市先康达生命科学有限公司 | 一种目的基因可调控的工程化免疫细胞及其制备方法和应用 |
| IL316221A (en) * | 2022-04-12 | 2024-12-01 | Minerva Biotechnologies Corp | Anti-MUC1* variant antibodies and their uses |
| KR20250024529A (ko) * | 2022-05-09 | 2025-02-18 | 미네르바 바이오테크놀로지 코포레이션 | 키메라 항원 수용체 및 il-18 수용체 조성물 및 이의 사용 방법 |
| US20240261406A1 (en) | 2023-02-02 | 2024-08-08 | Minerva Biotechnologies Corporation | Chimeric antigen receptor compositions and methods for treating muc1* diseases |
| WO2025080693A1 (en) | 2023-10-11 | 2025-04-17 | Minerva Biotechnologies Corporation | Anti-muc1* antibody drug complexes and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3087801A (en) * | 2000-02-04 | 2001-08-14 | Molecular Dynamics Inc | Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells |
| GB0802931D0 (en) * | 2008-02-18 | 2008-03-26 | Queen Mary & Westfield College | Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions |
| JP2012504961A (ja) * | 2008-10-06 | 2012-03-01 | ミネルバ バイオテクノロジーズ コーポレーション | Ｍｕｃ１＊抗体 |
| JP2012034668A (ja) * | 2010-08-12 | 2012-02-23 | Tohoku Univ | ヒト型化抗ｅｇｆｒ抗体リジン置換可変領域断片及びその利用 |
| CN108175856B (zh) * | 2012-08-14 | 2024-01-26 | 米纳瓦生物技术公司 | 干细胞增强疗法 |
| US11746159B2 (en) * | 2015-02-10 | 2023-09-05 | Minerva Biotechnologies Corporation | Humanized anti-MUC1* antibodies |
| JP2018510151A (ja) * | 2015-03-06 | 2018-04-12 | ソレント・セラピューティクス・インコーポレイテッド | Ｔｉｍ３に結合する抗体医薬 |
| EP3525804A4 (en) * | 2016-10-11 | 2020-09-09 | Minerva Biotechnologies Corporation | HUMANIZED ANTI-MUC1 * ANTIBODIES AND USE OF THE CLIVING ENZYME |
| WO2018132506A1 (en) * | 2017-01-10 | 2018-07-19 | The General Hospital Corporation | Chimeric antigen receptors based on alternative signal 1 domains |
| JP7411559B2 (ja) * | 2018-02-26 | 2024-01-11 | ミネルバ バイオテクノロジーズ コーポレーション | Ａｎｔｉ－ｍｕｃｉ＊抗体を用いた診断法 |
-
2020
- 2020-01-13 WO PCT/US2020/013410 patent/WO2020146902A2/en not_active Ceased
- 2020-01-13 CA CA3126391A patent/CA3126391A1/en active Pending
- 2020-01-13 JP JP2021540477A patent/JP2022527144A/ja active Pending
- 2020-01-13 AU AU2020205735A patent/AU2020205735A1/en active Pending
- 2020-01-13 CN CN202080020073.0A patent/CN113853386A/zh active Pending
- 2020-01-13 CN CN202510558379.6A patent/CN120484122A/zh active Pending
- 2020-01-13 EP EP20738367.0A patent/EP3908603A4/en active Pending
-
2021
- 2021-07-11 IL IL284772A patent/IL284772A/en unknown
- 2021-07-12 US US17/373,609 patent/US20220184120A1/en active Pending
-
2025
- 2025-07-29 JP JP2025126649A patent/JP2025172739A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021094037A5 (enExample) | ||
| JP2025065142A5 (enExample) | ||
| JP2021087455A5 (enExample) | ||
| JP2023059873A5 (enExample) | ||
| JP2019527557A5 (enExample) | ||
| JP2018525033A5 (enExample) | ||
| US11180553B2 (en) | Chimeric antigen receptor | |
| JPWO2020146902A5 (enExample) | ||
| RU2018109426A (ru) | Химерные антигенные рецепторы со встроенными контролируемыми функциями | |
| JP2020513754A5 (enExample) | ||
| US20190023764A1 (en) | Car having replicated binding motifs in a co-stimulatory domain | |
| JP2021500881A5 (enExample) | ||
| JP2020114264A5 (enExample) | ||
| JP2020533958A5 (enExample) | ||
| JP2020511136A5 (enExample) | ||
| JP2017519502A5 (enExample) | ||
| JP2020513829A5 (enExample) | ||
| JP2017524367A5 (enExample) | ||
| JP2017518071A5 (enExample) | ||
| JP2019533675A5 (enExample) | ||
| JPWO2020061498A5 (enExample) | ||
| JPWO2020228825A5 (enExample) | ||
| JPWO2020228824A5 (enExample) | ||
| JPWO2022027039A5 (enExample) | ||
| JPWO2019165116A5 (enExample) |